AMYRA Biotech AG

Name: AMYRA Biotech AG
Telephone: +41 61 515 07 70

Swiss Biotech Association

Member

AMYRA is developing a unique enzyme combination for curative care of Celiac Disease and Non-Celiac Gluten Sensitivity (NCGS), which represent major public health issues. AMYRA’s products have the potential to establish the standard of care and majorly impact the lives of affected people.

https://www.amyra.com
+41 61 515 07 70
office@amyra.com
Dr. Werner Tschollar

Facts & figures

Type of organization

Private company
Year of foundation

2013
Number of employees in Switzerland

1-9

Key business

Core competencies

Therapeutics/vaccines (human)

You may also be interested in

Bavarian Nordic Berna GmbH

Bavarian Nordic is a fully integrated vaccine company focused on the development, manufacturing and commercialization of life-saving vaccines. Our manufacturing site for oral vaccines is located in Thörishaus, 15 km southwest of Bern.
3174 Thörishaus

Member

Altorfer Engineering GmbH

Altorfer Engineering is a contractor and consulting company with expertise in providing engineering and project management services, due diligence assessments as well as technology transfer for aseptic drug product and biologics processes.
6300 Zug

Member

ATLyphe AG

ATLyphe is a Swiss biotech startup with the goal of developing antibody-based solutions engaging T cells for precision immunotherapy. We aim to not only provide less toxic and more precise treatments for current patients but also increase the total number of patients eligible to receive the therapy.
8006 Zürich

Member